Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Where the EU money came from

Funding by EU programme. Amounts are Shanghai Institute of Materia Medica, Chinese Academy of Sciences's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Shanghai Institute of Materia Medica, Chinese Academy of Sciences led 1 of them as coordinator. Each links to the official record.

• TCM-VASCCoordinator

  Discovery of bioactive natural compounds from Traditional Chinese Medicines (TCMs) used against Cardiovascular Disease (CVD)

  FP7 (2007 to 2013) · 2015–2015 · Project on CORDIS ↗

  €15ktheir share
• SILVERPartner

  Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses

  FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

  €175ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• Katholieke Universiteit LeuvenBelgium · 1 shared project
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
• Universiteit UtrechtNetherlands · 1 shared project
• Stichting Radboud UniversiteitNetherlands · 1 shared project
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
• Academisch Ziekenhuis LeidenNetherlands · 1 shared project
• Institut PasteurFrance · 1 shared project
• Universita Degli Studi di MilanoItaly · 1 shared project
• Universite D'Aix MarseilleFrance · 1 shared project
• Freie Universitaet BerlinGermany · 1 shared project
• Universitaet InnsbruckAustria · 1 shared project
• Universitatsklinikum HeidelbergGermany · 1 shared project
• Universitaet LeipzigGermany · 1 shared project
• Universitaet HamburgGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• antivirals
• cardiovascular diseases
• coronaviruses
• drug discovery
• medicinal chemistry
• mortality
• pharmaceutical drugs
• virology